Montalban-Bravo, Guillermo
Hammond, Danielle
DiNardo, Courtney D. http://orcid.org/0000-0001-9003-0390
Konopleva, Marina http://orcid.org/0000-0002-9347-2212
Borthakur, Gautam http://orcid.org/0000-0001-7679-6453
Short, Nicholas J. http://orcid.org/0000-0002-2983-2738
Ramos-Perez, Jorge
Guerra, Veronica
Kanagal-Shamanna, Rashmi http://orcid.org/0000-0001-7829-5249
Naqvi, Kiran
Sasaki, Koji http://orcid.org/0000-0002-9140-0610
Jabbour, Elias
Pemmaraju, Naveen
Kadia, Tapan M. http://orcid.org/0000-0002-9892-9832
Ravandi, Farhad
Daver, Naval
Estrov, Zeev
Pierce, Sherry
Kantarjian, Hagop http://orcid.org/0000-0002-1908-3307
Garcia-Manero, Guillermo http://orcid.org/0000-0002-3631-2482
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672, CA016672)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 14 January 2021
Revised: 26 February 2021
Accepted: 22 March 2021
First Online: 12 April 2021
Compliance with ethical standards
:
: KS: This author declares an advisory role with Pfizer Japan. EJ: This author declares research support and an advisory role with Adaptive, AbbVie, Amgen, Pfizer, Cyclacel LTD, Takeda, and Bristol Myers Squibb. CD: This author declares research support and an advisory role with Abbvie/Genentech, Agios, Celgene/BMS, ImmuneOnc, Novartis and Notable Labs, and honoraria from Takeda and Foghorn Therapeutics. MK: This author declares research support and an advisory role with Eli Lilly, AbbVie, Cellectis, Amgen, F. Hoffman La-Roche, Genentech, Ascentage, Kisoji, Reata Pharmaceuticals, Ablynx, Astra Zeneca, Agios, Forty-Seven, Stemline Therapeutics, and Calithera. T.K.: This author declares research support and an advisory role with Amgen, Bioline RX, Pfizer, Jazz, Bristol Myers Squibb, Celgene, Genentech, Pharmacyclics, Takeda, and AbbVie. FR: This author declares research support and an advisory role with Macrogeni, Selvita, Cyclacel LTD, Menarini Ricerche, and Xencor. HK: This author declares research support and an advisory role with Actinium, and research support from AbbVie, Agio, Amgen, Ariad, Astex, Bristol Myers Squibb, Cyclacel, Daiichi-Sankyo, Immunogen, Jazz Pharma, Novartis, and Pfizer. GG-M: This author declares research support and an advisory role with Bristol Myers Squibb, Astex, and Helsinn, and research support from Amphivena, Novartis, AbbVie, H3 Biomedicine, Onconova, and Merck. The remaining authors declare no conflicts of interest.